HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma	Advanced Hepatocellular Carcinoma (HCC)	Recruiting	Phase 2	2026-09-25		NCT06737913

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Hospital of Guangxi Medical University	22
First Affiliated Hospital of Fujian Medical University	88
Gansu Provincial Cancer Hospital	1
Henan Provincial People's Hospital	95
Hunan Provincial Cancer Hospital	2
Jinshazhou Hospital of Guangzhou University of Chinese Medicine	1
Shanghai Zhongshan Hospital	347
Sun Yat-sen University	606
The Seventh Affiliated Hospital of Sun Yat-sen University	6
West China Hospital	359

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Gansu Province Cancer Hospital	Lanzhou	China	1
Henan Cancer Hospital	Zhengzhou	China	98
Sun Yat-sen University Cancer Center	Guangzhou	China	4